🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
0.3470
-0.0198 (-5.40%)
At close: Nov 19, 2026, 4:00 PM EST
0.3600
+0.0130 (3.75%)
After-hours: Nov 19, 2026, 6:41 PM EST

Neumora Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-190.43-236.93-243.79-235.93-130.9-237.31
Depreciation & Amortization
0.030.210.630.670.590.54
Other Amortization
1.891.21----
Loss (Gain) From Sale of Assets
0.260.64----
Asset Writedown & Restructuring Costs
---63.913157
Loss (Gain) From Sale of Investments
-0.14-2.93-5.72-3.74-0.71-
Stock-Based Compensation
28.1429.8839.9917.248.34.27
Other Operating Activities
0.241.923.313.481.771.04
Change in Accounts Payable
1.410.072.87-0.58-1.25-0.76
Change in Other Net Operating Assets
-8.73-0.5119.76-8.32-5.7-0.2
Operating Cash Flow
-167.33-206.44-182.94-163.28-114.9-75.42
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
0.02--0.78-4.71-13.51-0.82
Sale of Property, Plant & Equipment
0.050.22----
Investment in Securities
42.58168.3-69.7869.09-154.5-
Investing Cash Flow
42.65168.52-70.5664.39-168.01-0.82

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-57.16----
Net Debt Issued (Repaid)
38.957.16----
Issuance of Common Stock
42.8119.9321.6236.232.663.47
Repurchase of Common Stock
----0.49--
Other Financing Activities
-0.45---3.8-0.92-1.21
Financing Cash Flow
81.2677.0921.6231.94115.74293.51

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-43.4239.17-231.89133.05-167.17217.27

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-167.31-206.44-183.71-167.99-128.41-76.24
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.93-1.26-1.15-2.58-4.72-3.48
Levered Free Cash Flow
-97.67-115.71-100.7-111.24-93.02-37.08
Unlevered Free Cash Flow
-94.85-114.91-100.7-111.24-93.02-37.08

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
5.181.5----
Cash Income Tax Paid
0.350.320.47---
Change in Working Capital
-7.32-0.4422.64-8.9-6.95-0.96
SEC Filings: 10-K · 10-Q